DONEGAL MUTUAL INSURANCE CO purchased $288K of DGICA

DONEGAL MUTUAL INSURANCE CO purchased 17,000 shares of DONEGAL GROUP INC (DGICA) at an average of $16.93 ($16.76–$17.10, $0.29M total) across 2 trades over 2026-05-29 to 2026-06-01.

Original reporting
SEC EDGAR · DONEGAL MUTUAL INSURANCE CO
Published Jun 2, 2026, 3:44 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 28, 2026, 3:41 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$DGICA
Neutral
medium confidence
Mentioned
$DGICA
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$DGICANeutralLow
01

Why it matters

The filing provides a factual update on insider ownership but limited market impact.

02

Market read

A modest insider buy that may slightly influence short-term sentiment for DGICA.

03

What to watch

Potential upcoming corporate actions or strategic moves not disclosed.

Relevance 5/10Novelty 4/10Timing: after-hours filing

Background

SEC Form 4 filing discloses insider transactions for public companies.

Company-level read

Ticker impact

$DGICANeutralMedium confidence
Context

Form 4 shows Donegal Mutual Insurance Co bought 17,000 shares of Donegal Group Inc for $287,806, increasing its stake to over 14 million shares.

Expected impact

slight upward pressure as market digests insider buying

Evidence & confidence

Purchase amount under $300k is unlikely to move price materially, but adds a positive bias.

Market effects

Minimal impact on insurance or financial services sector.

No broader regional effect.

Not globally material.

Counterpoint

The purchase could be a routine portfolio rebalancing rather than a strong endorsement.

Key entities

  • Donegal Group Inc

    Issuer of the shares purchased.

  • Donegal Mutual Insurance Co

    Insider reporting the purchase.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$DGICAMed

Donegal Group Inc (DGICA) Q3 2026 Earnings Call Highlights: Ninth Straight Profitable

Donegal Group (DGICA) reported Q3 2026 earnings, highlighting a 9th straight profitable quarter. CEO Kevin Burke discussed cloud migration timelines and AI integration. Commercial lines saw a 3.2% rise in core loss ratio due to workers' comp and liability losses. Personal lines improved with a 5.4% decline in net premiums written and a 146% increase in new business. Weather-related losses were $19.1M, and investment income rose 5% to $14.7M.

$DGICAMed

Donegal Group Q3 2026 slides: profitability holds amid soft market

Donegal Group Inc. (DGICA) reported Q3 2026 earnings with adjusted EPS of $0.50, beating estimates, but revenue of $209.7M missed forecasts. Underwriting profitability persisted with a combined ratio of 96.5%, though premiums declined. The stock rose 2.07% premarket. Management highlighted strategic initiatives and conservative investment strategies amid soft market conditions.

$DGICAMed

Donegal Group Inc. Announces Third Quarter and First Nine Months of 2026 Results

DONEGAL GROUP INC (DGICA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 Donegal Group Inc. Announces Third Quarter and First Nine Months of 2026 Results MARIETTA, Pa., Oct. 29, 2026 (GLOBE NEWSWIRE) -- Donegal Group Inc. (NASDAQ: DGICA) and (NASDAQ: DGICB) today reported its financial results for the third quarter and first nine months o